Primary Care Enhanced Services
Overview
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board is in the procurement stage of awarding a contract for Primary Care Enhanced Services, including general-practitioner services such as phlebotomy and specialised drug monitoring, in the UK region of East Midlands (UKF). This procurement, under the Provider Selection Regime regulations, follows a limited procedure and does not operate under the Public Contracts Regulations 2015. The contracting process commenced on 29 August 2025, with a standstill period allowing providers to make representations until 10 September 2025.
The contract duration is set from 1 April 2025 to 31 March 2026, valued at £111,564, and is intended to be awarded to Hereward Medical Centre (Lakeside). This tender presents significant opportunities for businesses specialising in healthcare services to align their offerings with regulatory requirements and enhance service delivery. It particularly suits existing providers who can demonstrate quality, innovation, and integration in healthcare solutions, given that the key criteria for awarding the contract include satisfying existing services to a sufficient standard.
SMEs in the healthcare sector may find a viable avenue to grow their business and expand their reach by engaging in collaborative efforts to provide comprehensive primary care and specialised treatment solutions in adherence to stringent healthcare regulations.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS111,564. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Lung Cancer Screening Programme on behalf of NHS Lincolnshire ICB in North Kesteven
- Environmental Controls - Direct Award Process C in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Musculoskeletal and Spinal Service in North Kesteven
- Market Engagement - NHS Lincolnshire ICB - Night Light Cafes Service in North Kesteven
- GP Practice Medical Cover for Hospice in the Hospital in North Kesteven